Pain Patches Carry Potential Risk for Fatal Overdose

California Duragesic Pain Patch Attorney
Patients who use Duragesic patches to treat chronic pain need to be aware of the health risks.

The Duragesic patch is designed to provide relief to patients who suffer from chronic pain caused by illness or other conditions. While the patches can help to ease their discomfort, patients who use them may also be at risk for a potentially fatal medication overdose.

The Duragesic Pain Patch, manufactured by Johnson & Johnson and its subsidiary, Janssen Pharamceutica, was first approved for the treatment of chronic pain by the U.S. Food and Drug Administration in 1997. The patches originally featured a non-permeable backing and a permeable medication release layer, which was designed to allow a controlled amount of fentanyl to be absorbed into the patient’s skin. Fentanyl is a concentrated opioid pain medication that is believed to be 80 to 100 times stronger than morphine. The patches are intended to provide pain relief for up to 72 hours and are available in 12.5, 25, 50, 75 and 100 mcg/hr doses.

In 2004, Janssen issued a recall of five lots of Duragesic patches after it was determined that some of them had the potential to leak, which could result in a fentanyl overdose. Additional recalls were ordered in 2008 of Duragesic patches as well as generic fentanyl patches after it was determined that there was the possibility of leakage.

The U.S. Food and Drug Administration has issued multiple safety communications advising patients and health care providers of the overdose risk associated with the Duragesic pain patches. The first warning came in 2005, after the FDA linked approximately 120 deaths to a fentanyl pain patch overdose. In December 2007, the FDA issued a second warning after more deaths were reported among Duragesic users. The FDA advised patients to keep the patches away from heat, as this could potentially increase the rate at which the medication is absorbed, resulting in an overdose.

Despite multiple recalls and repeated warnings from the FDA, the Duragesic pain patch and its generic counterparts continue to be manufactured and sold in the U.S. Patients who use a fentanyl patch to treat their chronic pain symptoms need to be aware of what signs may indicate a possible overdose. These include:

  • Difficulty breathing
  • Fatigue
  • Drowsiness
  • Confusion
  • Fainting Dizziness
  • Reduced pupils
  • Difficulty walking or talking

If you or a loved one experiences any of these symptoms while using a fentanyl pain patch, it’s important that you seek medical treatment immediately.

Numerous lawsuits have been filed in connection with the Duragesic pain patch, including multiple wrongful death lawsuits involving victims who died due to an overdose. If someone you love died while using a fentanyl patch to treat their chronic pain, you may be eligible to recover monetary damages. Contacting an experienced pain patch attorney is the first step in protecting your legal rights.

Nadrich & Cohen, LLP is currently investigating fentanyl overdose claims in all 50 states. For more information on filing a Duragesic pain patch lawsuit, call 1-800-718-4658 to begin your free initial case evaluation. There is never a fee unless compensation is recovered on your behalf.

Do I Have A Case?

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.


What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.


Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post

March 20, 2019

Valsartan Dangers: 3 Things You Should Know

Several drugs containing Valsartan have been  recalled in the U.S. because they contain impurities which may be cancer risks. You may be eligible for financial compensation if you took a drug containing Valsartan and have been diagnosed with cancer.

March 15, 2019

Expert Testifies Before House Subcommittee Regarding Talc Use And Ovarian Cancer Link

A United States House of Representatives subcommittee, on March 12th, 2019, looked into whether they should give the Food and Drug Administration (FDA) the power to more strictly regulate cosmetics, including talcum powder and products containing talc.


We are Personal Injury Lawyers representing accident victims throughout California.
For 30 years, the law firm of Nadrich & Cohen, LLP has helped injury victims
obtain the compensation they deserve.